Profile
ABOS NVO VRTX REGN MRNA SGEN
Company Name Acumen Pharmaceuticals, Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Moderna, Inc. Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $143.29M $643.34B $121.61B $114.55B $44.44B $43.15B
Employees 0.05K 66.02K 5.40K 13.68K 5.60K 3.26K
CEO Mr. Daniel J. O'Connell M.B.A. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. Stephane Bancel Mr. David R. Epstein B.Sc., M.B.A.
Ratings
ABOS NVO VRTX REGN MRNA SGEN
Quant Rating Score 3 5 4 4 3 3
Quant Rating Neutral Strong Buy Buy Buy Neutral Neutral
Trading
ABOS NVO VRTX REGN MRNA SGEN
Last Close $2.385 $145.42 $471.25 $1057.02 $115.95 $228.74
High 52 $9.72 $199.54 $485.53 $1071.19 $166.61 $228.9
Low 52 $1.86 $87.78 $338.18 $692.45 $69.51 $191.51
Price vs. 52 Week High -75.46 % -27.12 % -2.94 % -1.32 % -30.41 % -0.07 %
Price vs. 52 Week Low 28.23 % 65.66 % 39.35 % 52.65 % 66.81 % 19.44 %
Total Return
ABOS NVO VRTX REGN MRNA SGEN
1 Month Return -18.88 % 7.5 % 3.49 % 7.84 % -18.66 % 0 %
3 Month Return -37.07 % 14.99 % 15.1 % 10.72 % 11.91 % 0 %
6 Month Return -43.62 % 42.39 % 14.68 % 16.8 % 3.07 % 0 %
9 Month Return -42.81 % 58.41 % 35.48 % 29.22 % 12.24 % 8.03 %
YTD Return -37.89 % 40.57 % 15.82 % 20.35 % 16.59 % 0 %
1 Year Return -50.42 % -10.14 % 33.91 % 47.11 % -4.57 % 18.85 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABOS NVO VRTX REGN MRNA SGEN
Dividend Yield Percentage (TTM) - 0.14 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -1585.88 % 1.1 % 8.49 % 6.2 % -3.65 % -3.35 %
Dividend Per Share (TTM) - 0.2 % - - - -
Payout Ratio (TTM) - 47.03 % - - - -
Growth
ABOS NVO VRTX REGN MRNA SGEN
Asset Growth 57.75 % 30.35 % 25.23 % 13.23 % -28.74 % -1.21 %
Gross Profit Growth -8.88 % 32.32 % 9.25 % 6.49 % -85.12 % 22.93 %
Revenue Growth - 31.26 % 10.17 % 7.76 % -64.94 % 24.65 %
Revenue 3 Year -100 % 90.51 % 59.87 % 55.67 % 2356.27 % 91.84 %
Revenue 5 Year -100 % 124.2 % 218.58 % 110.3 % 1070.62 % 215.48 %
Revenue 10 Year -100 % 66.11 % 608.27 % 549.62 % 6447.35 % 494.04 %
EBIT Growth -35.15 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Net Income Growth -29.39 % 50.71 % 8.96 % -8.87 % -156.37 % 9.51 %
Net Income 3 Yeari Growth Per Share -490.65 % 106.79 % 34.59 % 13.48 % -529.9 % -764.83 %
Net Income 5 Yeari Growth Per Share -450.23 % 133.86 % 70.33 % 74.02 % -160.17 % -276.93 %
Net Income 10 Yeari Growth Per Share -450.23 % 98.61 % 809.6 % 871.12 % -2046.03 % -624.16 %
Operating Income Growth -35.15 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Operating Cash Flow Growth (CFG) -22.5 % 38.06 % -14.35 % -8.39 % -162.6 % 9.07 %
Operating 3 Year CFG -377.47 % 118.29 % 9.63 % 76.95 % -253.56 % -148.34 %
Operating 5 Year CFG -421.73 % 163.51 % 174.78 % 125.17 % -100.11 % -195.86 %
Operating 10 Year CFG -421.73 % 150.92 % 6084.35 % 713.56 % -4698.89 % -2622.09 %
EPS Growth -8 % 52.28 % 8.33 % -8.54 % -158.15 % 10.81 %
EPS Diluted Growth -8 % 52.37 % 8.35 % -9.03 % -161.39 % 10.81 %
Book Value Per Share 18.13 % 29 % 25.58 % 15.03 % -25.28 % -9.83 %
Share Holder 3 Year Equity Growth Per Share 1286.18 % 75.22 % 104.06 % 137.56 % 439.94 % 33.92 %
Share Holder 5 Year Equity Growth Per Share 2031.02 % 121.9 % 291.14 % 219.1 % 92.24 % 220.81 %
Share Holder 10 Year Equity Growth Per Share 2031.02 % 49.62 % 1030.79 % 1286.9 % 1519.81 % 691.19 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - 80.03 % - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth 29468.57 % 4.74 % 44.1 % 0.06 % 3.58 % -23.28 %
Free Cash Flow Growth -22.01 % 9.17 % -16.47 % -17.11 % -183.5 % 3.67 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022
Profitability
ABOS NVO VRTX REGN MRNA SGEN
Gross Profit Margin TTM 39.31 % 84.65 % 86.86 % 87.16 % 21.77 % 75.4 %
Return on Assets TTM -18.59 % 29.87 % 16.81 % 11.22 % -35.67 % -20.64 %
Return on Equity TTM -22.87 % 91.82 % 23.61 % 15.15 % -41.83 % -28.06 %
Return on Capital Employed TTM -22.49 % 82.5 % 20.67 % 12.53 % -35.81 % -29.5 %
Net Income Per EBT TTM 100 % 79.81 % 84.31 % 95.44 % 124.28 % 101.53 %
EBT Per Ebit TTM 85.04 % 101.7 % 114.62 % 104.74 % 93.44 % 93.47 %
EBIT Per Revenue TTM -22681.72 % 45.03 % 40.85 % 29.46 % -99.69 % -34.37 %
Cash Flow To Debt Ratio TTM -167.32 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Receivables Turnover TTM 1.53 3.87 5.68 2.51 13.32 3.64
Payables Turnover TTM 0.06 2.88 3.81 2.51 22.04 2.52
Inventory Turnover TTM - 1.12 1.65 0.62 13.67 1.07
Fixed Asset Turnover TTM 61.7 % 248.64 % 685.31 % 310.02 % 186.78 % 471.71 %
Asset Turnover TTM 0.1 % 81.71 % 42.57 % 38.12 % 30.81 % 63.3 %
Operating Cash Flow Per Share TTM -0.85 20.95 15.27 43.96 -7.54 -2.87
Free Cash Flow Per Share TTM -0.85 11.28 13.48 36.87 -9.61 -3.73
Cash Per Share TTM 422.18 % 208.61 % 3939.31 % 9758.35 % 2235.6 % 657.5 %
Operating Cash Flow Sales Ratio TTM -17499.31 % 38.24 % 38.74 % 36.17 % -55.91 % -23.48 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.06 % 53.85 % 88.22 % 83.87 % 127.41 % 129.82 %
Cash Flow Coverage Ratios TTM -167.32 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Price To Free Cash Flows Ratio TTM -2.82 88.98 34.95 28.82 -12.1 -61.54
Price To Operating Cash Flows Ratio TTM -2.81 48.3 30.85 24.04 -15.37 -79.67
Price Cash Flow Ratio TTM -2.81 48.3 30.85 24.04 -15.37 -79.67
Income Statement (TTM)
ABOS NVO VRTX REGN MRNA SGEN
Revenue $0B $232.26B $9.84B $13.12B $6.75B $1.96B
Gross Profit $-0B $196.5B $8.58B $11.3B $2.06B $1.55B
Gross Profit Ratio 0% 84.6% 87.17% 86.16% 30.52% 79.1%
EBITDA $-0.06B $112.94B $3.93B $5.13B $-3.21B $-0.62B
Net Income $-0.05B $83.68B $3.62B $3.95B $-4.71B $-0.61B
EPS Diluted -1.08 18.62 13.89 34.77 -12.34 -3.3
Balance Sheet (MRQ)
ABOS NVO VRTX REGN MRNA SGEN
Long Term Debt $0.03B $20.53B $0.72B $2.7B $1.22B $0.04B
Total Liabilities $0.04B $207.93B $5.15B $7.11B $4.57B $0.87B
Total Equity $0.27B $106.56B $17.58B $25.97B $13.85B $2.8B
Total Investments $0.24B $17.5B $3.45B $13.51B $4.68B $1.42B
Total Debt $0.03B $27.01B $0.81B $2.7B $1.24B $0.04B
Total Assets $0.31B $314.49B $22.73B $33.08B $18.43B $3.67B
Cash Flow Statement (TTM)
ABOS NVO VRTX REGN MRNA SGEN
Net Income $-0.05B $83.68B $3.62B $3.95B $-4.71B $-0.61B
Inventory $0B $-7.42B $-0.32B $-0.27B $0.75B $-0.23B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.04B $108.91B $3.54B $4.59B $-3.12B $-0.45B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.71B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 1.32
ABCL AbCellera Biologics Inc. 2.765
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.11
ABIO ARCA biopharma, Inc. 3.76
ABSI Absci Corporation 2.97
ABUS Arbutus Biopharma Corporation 3.13
ABVC ABVC BioPharma, Inc. 0.753
ABVX Abivax SA American Depositary Shares 13.39
ACAD ACADIA Pharmaceuticals Inc. 15.84
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 1.1
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.802
ACHV Achieve Life Sciences, Inc. 4.6
ACIU AC Immune SA 3.87
ACLX Arcellx, Inc. 53.25
ACRV Acrivon Therapeutics, Inc. Common Stock 6.1
ACST Acasti Pharma Inc. 2.825
ACXP Acurx Pharmaceuticals, Inc. 2.1601
ETFs With Exposure to ABOS
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 269.6
IBB iShares Biotechnology ETF 0.01258 135.96
BIB ProShares Ultra Nasdaq Biotechnology 0.00535472 57.9691
VXF Vanguard Extended Market Index Fund 0 168.19
IWC iShares Micro-Cap ETF 0.02388 113.005
CSML IQ Chaikin U.S. Small Cap ETF 0.17 34.9484
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 92.92
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 92.9
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 47.33
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 47.32
VBINX Vanguard Balanced Index Fund Investor Shares 0 47.33
BMED BlackRock Future Health ETF 0.03 24.7
DFAU Dimensional US Core Equity Market ETF 0.00048189 37.745
IBBQ Invesco Nasdaq Biotechnology ETF 0.017 22.49
DFAS Dimensional U.S. Small Cap ETF 0.00017292 59.77
DFAC Dimensional U.S. Core Equity 2 ETF 0.00002324 32.345
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.03546 6.097
VTSAX Vanguard Total Stock Market Index Fund 0 130.46
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01585 6.5425
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 127.24
VITSX Vanguard Total Stock Market Index Fund 0 130.48
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.01585 6.5515
IBRN iShares Neuroscience and Healthcare ETF 0.20913 23.7497
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000123949 92.13
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 127.25
DCOR Dimensional ETF Trust 0.00005219 59.79
VEMPX Vanguard Extended Market Index InstlPlus 0 314.01
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 244.75
Unlock